Antitumor Peptides from Marine Organisms
Open accessThe DOI matches its Crossref record; 134 of the 136 references it cites were found in a registry or an index.
Abstract
The biodiversity of the marine environment and the associated chemical diversity constitute a practically unlimited resource of new antitumor agents in the field of the development of marine bioactive substances. In this review, the progress on studies of antitumor peptides from marine sources is provided. The biological properties and mechanisms of action of different marine peptides are described; information about their molecular diversity is also presented. Novel peptides that induce apoptosis signal pathway, affect the tubulin-microtubule equilibrium and inhibit angiogenesis are presented in association with their pharmacological properties. It is intended to provide useful information for further research in the fields of marine antitumor peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591 · cited 1×
“Vascular endothelial growth factor (VEGF) and its receptor, VEGFR-2 (Flk-1/KDR), play a key role in tumor angiogenesis [80,81].”
BackgroundAngiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627 · cited 1×
“Both tumor growth and metastasis depend on the expansion of host vasculatures into tumors through angiogenesis [76–79].”
BackgroundApoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524 · cited 1×
“indispensable role and is a fundamental process in development, physiology and homeostasis [4–7].”
BackgroundDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Signal integration by JNK and p38 MAPK pathways in cancer development
Wagner, E. F., & Nebreda, Á. R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2694 · Cited by 2,586 · cited 1×
“Jun N-terminal kinases (JNKs) and p38 mitogen-activated protein kinases (MAPKs) play critical roles in the signaling mechanisms that orchestrate cellular responses to various types of cellular stress [35,36].”
BackgroundDhanasekaran, D. N., & Reddy, E. P. (2008) · Oncogene · doi:10.1038/onc.2008.301 · Cited by 1,525 · cited 2×
“Jun N-terminal kinases (JNKs) and p38 mitogen-activated protein kinases (MAPKs) play critical roles in the signaling mechanisms that orchestrate cellular responses to various types of cellular stress [35,36].”
BackgroundTargeting Apoptosis Pathways in Cancer Therapy
Ghobrial, I. M., Witzig, T. E., & Adjei, A. A. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.3.178 · Cited by 1,330
Reed, J. C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64779-7 · Cited by 1,288
The role of angiogenesis in tumor growth.
Folkman, J. (1992) · PubMed · Cited by 1,259
The CD95(APO-1/Fas) DISC and beyond
Peter, M. E., & Krammer, P. H. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401186 · Cited by 1,080 · cited 1×
“In mammals, there are two major signaling systems that result in the activation of caspases, the extrinsic death receptor pathway [16–19] and the intrinsic mitochondrial pathway [20,21].”
BackgroundBcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Kang, M. H., & Reynolds, C. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0144 · Cited by 1,016 · cited 1×
“These pathways are important for normal cellular homeostasis and play key roles in the pathogenesis of many diseases [21,26].”
BackgroundBcl-2 family proteins and cancer
Yip, K. W., & Reed, J. C. (2008) · Oncogene · doi:10.1038/onc.2008.307 · Cited by 881 · cited 2×
“Therefore, inhibition of Bcl-2 or induction of Bax becomes a good strategy for triggering an apoptotic process [22].”
BackgroundDeath receptor-induced cell killing
Thorburn, A. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2003.08.007 · Cited by 791 · cited 1×
“In mammals, there are two major signaling systems that result in the activation of caspases, the extrinsic death receptor pathway [16–19] and the intrinsic mitochondrial pathway [20,21].”
BackgroundApoptosis and cancer: mutations within caspase genes
Ghavami, S., Hashemi, M., Ande, S. R., Yeganeh, B., Xiao, W., Eshraghi, M., Bus, C. J., Kadkhoda, K., Wiechec, E., Halayko, A. J., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066944 · Cited by 713 · cited 1×
“Identification of caspases activators becomes another approach for the discovery of novel anticancer agents because caspases are involved in intrinsic and extrinsic apoptosis pathways [23,24].”
Background(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60862-3 · Cited by 510 · cited 1×
“Both tumor growth and metastasis depend on the expansion of host vasculatures into tumors through angiogenesis [76–79].”
BackgroundRedox signaling in angiogenesis: Role of NADPH oxidase
USHIOFUKAI, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.04.015 · Cited by 490 · cited 4×
“These pathways include VEGF-induced phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), serine/threonine protein kinase family protein kinase B (Akt), two tumor promoters CXC chemokine Receptor (CXCR4) and Hypoxia inducible factor 1alpha (HIF1α) [82,83].”
BackgroundInfluentialAngiogenesis and angiogenesis inhibition: An overview
Folkman, J. (1997) · Experientia Supplementum · doi:10.1007/978-3-0348-9006-9_1 · Cited by 410 · cited 1×
“Both tumor growth and metastasis depend on the expansion of host vasculatures into tumors through angiogenesis [76–79].”
BackgroundLuesch, H., Moore, R. E., Paul, V. J., Mooberry, S. L., & Corbett, T. H. (2001) · Journal of Natural Products · doi:10.1021/np010049y · Cited by 378
VEGF: an update on biological and therapeutic aspects
Ferrara, N. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00153-1 · Cited by 372 · cited 1×
“Vascular endothelial growth factor (VEGF) and its receptor, VEGFR-2 (Flk-1/KDR), play a key role in tumor angiogenesis [80,81].”
BackgroundDolastatin 10, a powerful cytostatic peptide derived from a marine animal
Bai, R., Petit, G. R., & Hamel, E. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90613-p · Cited by 321
Mitochondrial control of apoptosis: an introduction
Kroemer, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00614-4 · Cited by 317 · cited 1×
“In mammals, there are two major signaling systems that result in the activation of caspases, the extrinsic death receptor pathway [16–19] and the intrinsic mitochondrial pathway [20,21].”
BackgroundDidemnins: Antiviral and Antitumor Depsipeptides from a Caribbean Tunicate
Rinehart, K. L., Gloer, J. B., Hughes, R. G., Renis, H. E., McGovren, J. P., Swynenberg, E. B., Stringfellow, D. A., Kuentzel, S. L., & Li, L. H. (1981) · Science · doi:10.1126/science.7233187 · Cited by 308
Cell surface Death Receptor signaling in normal and cancer cells
Özören, N., & El-Deiry, W. S. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00131-1 · Cited by 289 · cited 1×
“In mammals, there are two major signaling systems that result in the activation of caspases, the extrinsic death receptor pathway [16–19] and the intrinsic mitochondrial pathway [20,21].”
BackgroundBai, R. L., Pettit, G. R., & Hamel, E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44880-0 · Cited by 286 · cited 1×
“The tripeptide did not significantly inhibit either vincristine binding or nucleotide exchange [63].”
BackgroundThe mitochondrial death pathway: a promising therapeutic target in diseases
Gupta, S., Kass, G. E. N., Szegezdi, E., & Joseph, B. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00697.x · Cited by 278 · cited 2×
“In mammals, there are two major signaling systems that result in the activation of caspases, the extrinsic death receptor pathway [16–19] and the intrinsic mitochondrial pathway [20,21].”
BackgroundSchirmer, T., Huber, R., Schneider, M., Bode, W., Miller, M., & Hackert, M. L. (1986) · Journal of Molecular Biology · doi:10.1016/s0022-2836(86)80013-4 · Cited by 260 · cited 4×
“C-phycocyanin, a tetrapyrrole-protein complex isolated from the cyanobacteria Agmenellum quadruplicatum, Mastigocladus laminosus [33] and Spirulina platensis, could induce the activation of pro-apoptotic gene and down-regulation of anti-apoptotic gene expression, then facilitate the transduction of apoptosis signals t…”
BackgroundInfluentialStructures of the didemnins, antiviral and cytotoxic depsipeptides from a Caribbean tunicate
Rinehart, K. L., Gloer, J. B., Cook, J. C., Mizsak, S. A., & Scahill, T. A. (1981) · Journal of the American Chemical Society · doi:10.1021/ja00397a055 · Cited by 256 · cited 1×
“Didemnins, originally reported in 1981 [44,45], are a family of depsipeptides with antitumor, antiviral and immunosuppressive activities primarily isolated from the Caribbean tunicate Trididemnum solidum, but later obtained from other species of the same genus [46,47].”
BackgroundTubulin and microtubules as targets for anticancer drugs.
Hadfield, J. A., Ducki, S., Hirst, N., & McGown, A. T. (2003) · PubMed · Cited by 247
Apoptosis in cancer: Key molecular signaling pathways and therapy targets
Burz, C., Berindan-Neagoe, I., Balacescu, O., & Irimie, A. (2009) · Acta Oncologica · doi:10.1080/02841860902974175 · Cited by 245 · cited 1×
“treatment failures [8,9].”
Chiavarina, B., Whitaker-Menezes, D., Migneco, G., Martinez-Outschoorn, U. E., Pavlides, S., Howell, A., Tanowitz, H. B., Casimiro, M. C., Wang, C., Pestell, R. G., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12908 · Cited by 222 · cited 1×
“HIF1α induces VEGF aggregation, actions known to be important for cellular survival and endovascular differentiation [84,85].”
BackgroundShark Cartilage Contains Inhibitors of Tumor Angiogenesis
Lee, A., & Langer, R. (1983) · Science · doi:10.1126/science.6193581 · Cited by 206 · cited 1×
“Rather than being a specific monomolecular compound, AE-941 is a defined standardized liquid extract comprising the <500 kDa fraction from the cartilage of shark, Squalus acanthias, directly inhibits tumor cell growth and angiogenesis [86,87].”
BackgroundRowinsky, E. K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2889 · Cited by 197 · cited 1×
“indispensable role and is a fundamental process in development, physiology and homeostasis [4–7].”
BackgroundLinington, R. G., Edwards, D. J., Shuman, C. F., McPhail, K. L., Matainaho, T., & Gerwick, W. H. (2008) · Journal of Natural Products · doi:10.1021/np070280x · Cited by 190 · cited 2×
“Some other antitumor peptides including Symplocamide A [125,126], Apratoxin D [127,128] and Mitsoamide [129] have been isolated recently from Cyanobacteria.”
BackgroundBcl‐2 family proteins: The sentinels of the mitochondrial apoptosis pathway
Wong, W. W., & Puthalakath, H. (2008) · IUBMB Life · doi:10.1002/iub.51 · Cited by 179 · cited 1×
“In the intrinsic mitochondrial pathway, at least 18 pro- and anti-apoptotic proteins of the Bcl-2 family are pivotal regulators of apoptosis, Bax as a proapoptotic member of the Bcl-2 family is very influential in the pro- and anti-apoptotic balance by regulating mitochondrial functions [22,27].”
BackgroundTargeted manipulation of apoptosis in cancer treatment
Call, J. A., Eckhardt, S. G., & Camidge, D. R. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70209-2 · Cited by 165 · cited 2×
“indispensable role and is a fundamental process in development, physiology and homeostasis [4–7].”
BackgroundLoganzo, F., Discafani, C. M., Annable, T., Beyer, C. F., Musto, S., Hari, M., Tan, X., Hardy, C., Hernandez, R., Baxter, M., et al. (2003) · PubMed · Cited by 162
Anderson, H. J., Coleman, J. E., Andersen, R. J., & Roberge, M. (1996) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050564 · Cited by 160 · cited 1×
“, binds to the Vinca-peptide site in tubulin, disrupts normal microtubule dynamics; depolymerize microtubules [69,70].”
BackgroundGutiérrez, M., Suyama, T. L., Engene, N., Wingerd, J. S., Matainaho, T., & Gerwick, W. H. (2008) · Journal of Natural Products · doi:10.1021/np800121a · Cited by 156 · cited 2×
“Some other antitumor peptides including Symplocamide A [125,126], Apratoxin D [127,128] and Mitsoamide [129] have been isolated recently from Cyanobacteria.”
BackgroundNew cyclic peptides with cytotoxic activity from the ascidian Lissoclinum patella
Degnan, B. M., Hawkins, C. J., Lavin, M. F., McCaffrey, E. J., Parry, D. L., Van den Brenk, A. L., & Watters, D. J. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00126a034 · Cited by 150 · cited 3×
“D (1–4) [97], Lissoclinamides [46,98,99] and Mollamides [100,101] , which display potent cytotoxicity, but their exact mechanism have not been well documented.”
BackgroundMicrotubulin Binding Sites as Target for Developing Anticancer Agents
Islam, M., & Iskander, M. (2004) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557043402946 · Cited by 146 · cited 1×
“Therefore, there is a strong need to design and develop new natural analogs as antimitotic agents to interact with tubulin at sites different from those of Vinca alkaloids and taxanes [59].”
BackgroundGarcía‐Fernández, L., Losada, A., Alcaide, V., Alvarez, A. M., Cuadrado, A., González, L. E., Nakayama, K., Nakayama, K., Fernandez-Sousa, J. M., Múñoz, A., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205972 · Cited by 143 · cited 1×
“Protein kinase C delta (PKC-d) mediates the cytotoxic effect of Aplidin and that it is concomitantly processed and activated late in the apoptotic process by a caspases mediated mechanism [39].”
BackgroundUrdiales, J. L., Morata, P., de Castro, I. N., & Sánchez‐Jiménez, F. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04151-1 · Cited by 142 · cited 6×
“Aplidine’s mechanism of action involves several pathways, including cell cycle arrest, inhibition of protein synthesis and anti-angiogenic activity [131].”
BackgroundInfluentialOdaka, C., Sanders, M. L., & Crews, P. (2000) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.7.6.947-952.2000 · Cited by 141 · cited 1×
“Transformed cell lines were more susceptible to Jasplakinolide-induced apoptosis than normal nontransformed cells [29].”
BackgroundBioactive Compounds from Aquatic and Terrestrial Sources
RINEHART, K. L. J., Holt, T. G., Fregeau, N. L., Keifer, P. A., Wilson, G. R., Perun, T. J., Sakai, R., Thompson, A. G., Stroh, J. G., Shield, L. S., et al. (1990) · Journal of Natural Products · doi:10.1021/np50070a001 · Cited by 126 · cited 1×
“continues to be a main focus in clinical investigation, being the first marine natural product currently in clinical trials as an anti-cancer agent [51,52].”
BackgroundThe marine lipopeptide somocystinamide A triggers apoptosis via caspase 8
Wrasidlo, W., Mielgo, A., Torres, V. A., Barbero, S., Stoletov, K., Suyama, T. L., Klemke, R. L., Gerwick, W. H., Carson, D. A., & Stupack, D. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712198105 · Cited by 118
Orbiculamide A: a novel cytotoxic cyclic peptide from a marine sponge Theonella sp
Fusetani, N., Sugawara, T., Matsunaga, S., & Hirota, H. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00020a080 · Cited by 117 · cited 2×
“34 μg/mL), but also against different melanoma cell lines [104].”
BackgroundThe synthetic challenge of diazonamide A, a macrocyclic indole bis-oxazole marine natural product
Lachia, M., & Moody, C. J. (2008) · Natural Product Reports · doi:10.1039/b705663j · Cited by 117 · cited 2×
“Diazonamide A and the analog bind weakly to unpolymerized tubulin but strongly to microtubule ends [65,66].”
BackgroundCruz‐Monserrate, Z., Vervoort, H. C., Bai, R., Newman, D. J., Howell, S. B., Los, G., Mullaney, J. T., Williams, M. D., Pettit, G. R., Fenical, W., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1273 · Cited by 117 · cited 3×
“Diazonamide A and the analog bind weakly to unpolymerized tubulin but strongly to microtubule ends [65,66].”
BackgroundLi, B., Gao, M., Zhang, X., & Chu, X. (2006) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20050142 · Cited by 114 · cited 4×
“Some other peptides from marine sources, such as Somocystinamide A [31,32] and C-phycocyanin (C-PC) [33,34] have been observed to display potent caspases-dependent anti-apoptotic activity in different cancer cells.”
BackgroundInfluentialvon Schwarzenberg, K., & Vollmar, A. M. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.07.004 · Cited by 111
Mechanism of Inhibition of a Poxvirus Topoisomerase by the Marine Natural Product Sansalvamide A
Hwang, Y. S., Rowley, D. C., Rhodes, D., Gertsch, J., Fenical, W., & Bushman, F. D. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.6.1049 · Cited by 110 · cited 3×
“Some other peptides from marine sources, such as Sansalvamide A [53,54], Cycloxazoline [55,56] and virenamides A–C [57] have been observed to display potent anti-apoptotic activity in different cancer cells but the exact targets by these chemicals have not yet been identified.”
BackgroundStyelin D, an Extensively Modified Antimicrobial Peptide from Ascidian Hemocytes
Taylor, S. W., Craig, A. G., Fischer, W. H., Park, M., & Lehrer, R. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006762200 · Cited by 109 · cited 2×
“A lot of peptides were isolated from ascidians, including patellamides [91–94], Styelin D [95], Eusynstyelamide [96], botryllamides A–D (1–4) [97], Lissoclinamides [46,98,99] and Mollamides [100,101] , which display potent cytotoxicity, but their exact mechanism have not been well documented.”
BackgroundYu, Z., Lang, G., Kajahn, I., Schmaljohann, R., & Imhoff, J. F. (2008) · Journal of Natural Products · doi:10.1021/np070580e · Cited by 108 · cited 3×
“Scopularides A and B Fungus Scopulariopsis brevicaulis Cyclodepsipeptide Unknown [124]”
BackgroundApoptosis in normal and cancer stem cells
Iannolo, G., Conticello, C., Memeo, L., & Maria, R. D. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.09.004 · Cited by 106 · cited 1×
“indispensable role and is a fundamental process in development, physiology and homeostasis [4–7].”
BackgroundTamandarins A and B: New Cytotoxic Depsipeptides from a Brazilian Ascidian of the Family Didemnidae
Vervoort, H., Fenical, W., & Epifanio, R. D. A. (2000) · The Journal of Organic Chemistry · doi:10.1021/jo991425a · Cited by 104 · cited 1×
“Until today, a lot of Didemnin analogues have been prepared semisynthetically and their biological activities evaluated, including cytotoxicity and antiviral and immunosuppressive properties [46,50].”
BackgroundChun, H. G., Davies, B., Hoth, D. F., Suffness, M., Plowman, J., Flora, K. P., Grieshaber, C. K., & Leyland-Jones, B. R. (1986) · Investigational New Drugs · doi:10.1007/bf00179597 · Cited by 98
Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp. and Siphonochalina spp. sponges
Gamble, W. R., Durso, N. A., Fuller, R. W., Westergaard, C. K., Johnson, T. R., Sackett, D. L., Hamel, E., Cardellina, J. H., & Boyd, M. R. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00089-9 · Cited by 98
Edler, M., Fernandez, A. M., Lassota, P., Ireland, C. M., & Barrows, L. R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00898-x · Cited by 97
Faivre, S. J., Chièze, S., Delbaldo, C., Vago, N. A., Guzmán, C., Lázaro, L. L., Lozahic, S., Jimeno, J. M., Pico, F., Armand, J. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.357 · Cited by 97 · cited 1×
“Aplidine, also called plitidepsin in clinical trials, is well-tolerated with minor toxicity in finished Phase I clinical trials [40–42].”
BackgroundMollamides B and C, Cyclic Hexapeptides from the Indonesian Tunicate Didemnum molle
Donia, M. S., Wang, B., Dunbar, D. C., Desai, P. V., Patny, A., Avery, M. A., & Hamann, M. T. (2008) · Journal of Natural Products · doi:10.1021/np700718p · Cited by 95 · cited 2×
“D (1–4) [97], Lissoclinamides [46,98,99] and Mollamides [100,101] , which display potent cytotoxicity, but their exact mechanism have not been well documented.”
BackgroundTherapeutic targeting of apoptosis pathways in cancer
Ziegler, D. S., & Kung, A. L. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f310f6 · Cited by 94 · cited 1×
“As such, modulation of apoptotic pathways and selective induction of apoptosis by chemical agents are likely to be a promising approach for cancer therapy [6,10–15].”
BackgroundAntitumor and Cytotoxic Compounds from Marine Organisms
Schmitz, F. J., Bowden, B. F., & Toth, S. I. (1993) · Springer eBooks · doi:10.1007/978-1-4899-2391-2_7 · Cited by 93 · cited 5×
“Lissoclinamides (Lissoclinamides 4 and 5), a cyclic peptide isolated from the aplousobranch ascidian Lissoclinum patella [98], showed relevant antineoplastic as well as other pharmacological properties against human fibroblast and bladder carcinoma cell lines and normal lymphocytes [46].”
BackgroundInfluentialMilnamide A, an unusual cytotoxic tripeptide from the marine sponge Auletta cf. constricta
Crews, P., Farias, J. J., Emrich, R., & Keifer, P. A. (1994) · The Journal of Organic Chemistry · doi:10.1021/jo00090a008 · Cited by 92
Hawkins, C. J., Lavin, M. F., Marshall, K. A., van den Brenk, A. L., & Watters, D. J. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00168a016 · Cited by 90 · cited 4×
“D (1–4) [97], Lissoclinamides [46,98,99] and Mollamides [100,101] , which display potent cytotoxicity, but their exact mechanism have not been well documented.”
BackgroundInfluentialNew Cyclic Peptides from the Ascidian Lissoclinumpatella
Fu, X., Do, T., Schmitz, F. J., Andrusevich, V., & Engel, M. H. (1998) · Journal of Natural Products · doi:10.1021/np9802872 · Cited by 89 · cited 1×
“A lot of peptides were isolated from ascidians, including patellamides [91–94], Styelin D [95], Eusynstyelamide [96], botryllamides A–D (1–4) [97], Lissoclinamides [46,98,99] and Mollamides [100,101] , which display potent cytotoxicity, but their exact mechanism have not been well documented.”
BackgroundCycloxazoline: A cytotoxic cyclic hexapeptide from the ascidian lissoclinum bistratum.
Hambley, T. W., Hawkins, C. J., Lavin, M. F., van den Brenk, A. L., & Watters, D. J. (1992) · Tetrahedron · doi:10.1016/s0040-4020(01)88146-1 · Cited by 89 · cited 4×
“Some other peptides from marine sources, such as Sansalvamide A [53,54], Cycloxazoline [55,56] and virenamides A–C [57] have been observed to display potent anti-apoptotic activity in different cancer cells but the exact targets by these chemicals have not yet been identified.”
BackgroundInfluentialApoptosis signaling in cancer stem cells
Fulda, S., & Pervaiz, S. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.06.010 · Cited by 89 · cited 1×
“treatment failures [8,9].”
New Peptides Isolated from Lyngbya Species: A Review
Liu, L., & Rein, K. S. (2010) · Marine Drugs · doi:10.3390/md8061817 · Cited by 88 · cited 2×
“Some other antitumor peptides including Symplocamide A [125,126], Apratoxin D [127,128] and Mitsoamide [129] have been isolated recently from Cyanobacteria.”
BackgroundMarine Animal Biosynthetic Constituents For Cancer Chemotherapy
Pettit, G. R., Kamano, Y., Fujii, Y., Herald, C. L., Inoue, M., Brown, P., Gust, D., Kitahara, K., Schmidt, J. M., Doubek, D. L., et al. (1981) · Journal of Natural Products · doi:10.1021/np50016a016 · Cited by 88 · cited 1×
“Dolastatin 10, a linear pentapeptide containing several unique amino acid subunits (Figure 3A), was derived from the marine mollusk Dolabella auricularia; it is the most potent member of a large class of related peptides [60,61].”
BackgroundAntiangiogenic activity of aplidine, a new agent of marine origin
Taraboletti, G., Poli, M., Dossi, R., Manenti, L., Borsotti, P., Faircloth, G. T., Broggini, M., D’Incalci, M., Ribatti, D., & Giavazzi, R. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601864 · Cited by 87 · cited 1×
“Aplidine’s mechanism of action involves several pathways, including cell cycle arrest, inhibition of protein synthesis and anti-angiogenic activity [131].”
BackgroundBai, R., Durso, N. A., Sackett, D. L., & Hamel, E. (1999) · Biochemistry · doi:10.1021/bi991323e · Cited by 87 · cited 5×
“Sponge is another rich resource of peptides, such as Geodiamolides A–G [102,103], Orbiculamide A [104], Koshikamide B [105], Phakellistatins [106–109], Microcionamides A and B [110], Halicylindramides [111], Haligramides [112], Hemiasterlin [113], Milnamide A [114], Corticiamide A [115], Theopapuamide [116], Taumycins…”
BackgroundInfluentialThe Complexity of TNF‐Related Apoptosis‐Inducing Ligand
Abe, K., Kurakin, A. V., MOHSENI‐MAYBODI, M., Kay, B. K., & Khosravi‐Far, R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05598.x · Cited by 87 · cited 1×
“In mammals, there are two major signaling systems that result in the activation of caspases, the extrinsic death receptor pathway [16–19] and the intrinsic mitochondrial pathway [20,21].”
BackgroundKeenamide A, a Bioactive Cyclic Peptide from the Marine Mollusk Pleurobranchus forskalii
Wesson, K. J., & Hamann, M. T. (1996) · Journal of Natural Products · doi:10.1021/np960153t · Cited by 87 · cited 3×
“Keenamide A exhibited significant activity against the P388, A549, MEL-20, and HT-29 tumor cell lines [121].”
BackgroundInfluentialDepenbrock, H., Peter, R., Faircloth, G. T., Manzanares, I., Jimeno, J. M., & Hanauske, A.-R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.570 · Cited by 85 · cited 6×
“Aplidine’s mechanism of action involves several pathways, including cell cycle arrest, inhibition of protein synthesis and anti-angiogenic activity [131].”
BackgroundInfluentialFishing for drugs from the sea: status and strategies
Vries, D. J. D., & Beart, P. M. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89045-8 · Cited by 82 · cited 1×
“Recently, marine peptides have opened a new perspective for pharmaceutical developments [1].”
BackgroundTheopapuamide, a Cyclic Depsipeptide from a Papua New Guinea Lithistid Sponge Theonella swinhoei
Ratnayake, A. S., Bugni, T. S., Feng, X., Harper, M. K., Skalicky, J. J., Mohammed, K. A., Andjelic, C. D., Barrows, L. R., & Ireland, C. M. (2006) · Journal of Natural Products · doi:10.1021/np060229d · Cited by 81 · cited 2×
“Sponge is another rich resource of peptides, such as Geodiamolides A–G [102,103], Orbiculamide A [104], Koshikamide B [105], Phakellistatins [106–109], Microcionamides A and B [110], Halicylindramides [111], Haligramides [112], Hemiasterlin [113], Milnamide A [114], Corticiamide A [115], Theopapuamide [116], Taumycins…”
BackgroundKulokekahilide-2, a Cytotoxic Depsipeptide from a Cephalaspidean Mollusk Philinopsis speciosa
Nakao, Y., Yoshida, W. Y., Takada, Y., Kimura, J., Yang, L., Mooberry, S. L., & Scheuer, P. J. (2004) · Journal of Natural Products · doi:10.1021/np049949f · Cited by 79 · cited 2×
“Kulokekahilide-1 [122], Kulokekahilide-2 [123] and Scopularide A and B [124], also elicit antitumor activity via unknown mechanisms.”
BackgroundIsolation and Structure of the Marine Sponge Cell Growth Inhibitory Cyclic Peptide Phakellistatin 1
Pettit, G. R., Cichacz, Z., Barkoczy, J., Dorsaz, A.-C., Herald, D. L., Williams, M. D., Doubek, D. L., Schmidt, J. M., Tackett, L. P., Brune, D. C., et al. (1993) · Journal of Natural Products · doi:10.1021/np50092a011 · Cited by 78 · cited 1×
“Phakellistatins, isolated from two Indo-Pacific sponges, Phakellia costata and Stylotella aurantium, are a group of proline rich cyclic heptapeptides; Phakellistatin 1, showed potent activity against P388 murine leukemia cells and other different melanoma cell lines [106].”
BackgroundApoptosis pathways as promising targets for skin cancer therapy
Eberle, J., Fecker, L. F., Forschner, T., Ulrich, C., Röwert‐Huber, J., & Stockfleth, E. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07855.x · Cited by 77 · cited 1×
“As such, modulation of apoptotic pathways and selective induction of apoptosis by chemical agents are likely to be a promising approach for cancer therapy [6,10–15].”
BackgroundBiologically active compounds from marine organisms
Blunden, G. (2001) · Phytotherapy Research · doi:10.1002/ptr.982 · Cited by 77
Highly N-Methylated Linear Peptides Produced by an Atypical Sponge-Derived Acremonium sp.
Boot, C. M., Tenney, K., Valeriote, F. A., & Crews, P. (2006) · Journal of Natural Products · doi:10.1021/np0503653 · Cited by 76 · cited 1×
“Sponge is another rich resource of peptides, such as Geodiamolides A–G [102,103], Orbiculamide A [104], Koshikamide B [105], Phakellistatins [106–109], Microcionamides A and B [110], Halicylindramides [111], Haligramides [112], Hemiasterlin [113], Milnamide A [114], Corticiamide A [115], Theopapuamide [116], Taumycins…”
BackgroundScleritodermin A, a Cytotoxic Cyclic Peptide from the Lithistid Sponge Scleritoderma nodosum
Schmidt, E. W., Raventós-Suárez, C., Bifano, M., Menendez, A. T., Fairchild, C. R., & Faulkner, D. J. (2004) · Journal of Natural Products · doi:10.1021/np034035z · Cited by 76 · cited 2×
“Scleritodermin A showed significant in vitro cytotoxicity against human tumor cell lines and inhibited tubulin polymerization [67,68].”
BackgroundSimmons, T. L., Nogle, L. M., Media, J. E., Valeriote, F. A., Mooberry, S. L., & Gerwick, W. H. (2009) · Journal of Natural Products · doi:10.1021/np9001674 · Cited by 75 · cited 5×
“DMMC exhibited potent and selective anti-solid tumor Mar. Drugs 2011, 9 1847 activity against the HCT-116 human colon carcinoma cell line via disruption of cellular microfilament networks.”
BackgroundMethodInfluentialNogle, L. M., & Gerwick, W. H. (2002) · Organic Letters · doi:10.1021/ol017275j · Cited by 72 · cited 3×
“assemblage of marine cyanobacteria Lipopeptide Caspase-8 activation [31,32]”
BackgroundPatellamide E: a New Cyclic Peptide from the Ascidian Lissoclinum patella
McDonald, L. A., & Ireland, C. M. (1992) · Journal of Natural Products · doi:10.1021/np50081a016 · Cited by 71 · cited 1×
“A lot of peptides were isolated from ascidians, including patellamides [91–94], Styelin D [95], Eusynstyelamide [96], botryllamides A–D (1–4) [97], Lissoclinamides [46,98,99] and Mollamides [100,101] , which display potent cytotoxicity, but their exact mechanism have not been well documented.”
BackgroundJaspamide from the Marine Sponge Jaspis johnstoni
Braekman, J. C., Daloze, D., Moussiaux, B., & Riccio, R. (1987) · Journal of Natural Products · doi:10.1021/np50053a048 · Cited by 70 · cited 1×
“Jaspamide (Jasplakinolide), isolated from marine sponge Jaspis johnstoni, is a cyclic depsipeptide with a 15-carbon macrocyclic ring containing three amino acid residues (Figure 2A) [28].”
BackgroundMicrocionamides A and B, Bioactive Peptides from the Philippine Sponge Clathria (Thalysias) abietina
Davis, R. A., Mangalindan, G. C., Bojo, Z. P., Antemano, R. R., Rodriguez, N. O., Concepción, G. P., Samson, S. C., de Guzman, D., Cruz, L. J., Taşdemir, D., et al. (2004) · The Journal of Organic Chemistry · doi:10.1021/jo040129h · Cited by 69 · cited 3×
“Microcionamides A and B , new linear peptides cyclized via a cysteine moiety and isolated from the Philippine Sponge Clathria (Thalysias) abietina, exhibited significant cytotoxicity against the human breast tumor cells lines MCF-7 and SKBR-3 and displayed inhibitory activity against Mycobacterium tuberculosis H37Ra […”
BackgroundMaroun, J., Bélanger, K., Seymour, L., Matthews, S. W., Roach, J., Dionne, J., Soulières, D., Stewart, D. J., Goel, R., Charpentier, D., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl165 · Cited by 68
Carroll, A. R., Bowden, B., Coll, J., Hockless, D., Skelton, B. W., & White, A. (1994) · Australian Journal of Chemistry · doi:10.1071/ch9940061 · Cited by 67
Haligramides A and B, Two New Cytotoxic Hexapeptides from the Marine Sponge Haliclona nigra
Rashid, M. A., Gustafson, K. R., Boswell, J. L., & Boyd, M. R. (2000) · Journal of Natural Products · doi:10.1021/np000051+ · Cited by 66 · cited 2×
“Sponge is another rich resource of peptides, such as Geodiamolides A–G [102,103], Orbiculamide A [104], Koshikamide B [105], Phakellistatins [106–109], Microcionamides A and B [110], Halicylindramides [111], Haligramides [112], Hemiasterlin [113], Milnamide A [114], Corticiamide A [115], Theopapuamide [116], Taumycins…”
BackgroundPatellamide F, a New Cytotoxic Cyclic Peptide from the Colonial Ascidian Lissoclinum patella
Rashid, M. A., Gustafson, K. R., Cardellina, J. H., & Boyd, M. R. (1995) · Journal of Natural Products · doi:10.1021/np50118a020 · Cited by 66
Pettit, G. R., Tan, R., Ichihara, Y., Williams, M. D., Doubek, D. L., Tackett, L. P., Schmidt, J. M., Cerny, R. L., Boyd, M. R., & Hooper, J. N. A. (1995) · Journal of Natural Products · doi:10.1021/np50120a025 · Cited by 63
A Further Study of the Cytotoxic Constituents of a Milnamide-Producing Sponge
Sonnenschein, R. N., Farias, J. J., Tenney, K., Mooberry, S. L., Lobkovsky, E. B., Clardy, J., & Crews, P. (2004) · Organic Letters · doi:10.1021/ol036446c · Cited by 63 · cited 2×
“are a group of cytotoxic peptides in which there is three amino acids forming a cyclic peptide with a common polyketide unit [102,103].”
BackgroundInduction of apoptosis and CD10/neutral endopeptidase expression by jaspamide in HL-60 line cells
Cioca, D., & Kitano, K. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8515-6 · Cited by 63 · cited 1×
“the observed cytoplasmic and membrane changes in apoptosing cells, and also a caspases-dependent cell death, which is responsible for PARP proteolysis [30].”
BackgroundRole of MAP kinases and their cross-talk in TGF-β1-induced apoptosis in FaO rat hepatoma cell line
Park, H., Kim, B.-C., Kim, S., & Choi, K. S. (2002) · Hepatology · doi:10.1053/jhep.2002.33205 · Cited by 60 · cited 1×
“Some marine anticancer peptides can activate the Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinases (MAPK) pathways that lead to the release of cytochrome c (Cyt C) from mitochondria [25].”
BackgroundThe marine sponge metabolite mycothiazole: A novel prototype mitochondrial complex I inhibitor
Morgan, J. B., Mahdi, F., Liu, Y., Coothankandaswamy, V., Jekabsons, M. B., Johnson, T. A., Sashidhara, K. V., Crews, P., Nagle, D. G., & Zhou, Y. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.06.072 · Cited by 56 · cited 1×
“mitochondrial respiration at complex I (NADH-ubiquinone oxidoreductase), may serve as a valuable molecular probe for mitochondrial biology and HIF-mediated hypoxic signaling [90].”
BackgroundA New Cytotoxic and Tubulin-Interactive Milnamide Derivative from a Marine Sponge Cymbastela sp.
Chevallier, C., Richardson, A. D., Edler, M., Hamel, E., Harper, M. K., & Ireland, C. M. (2003) · Organic Letters · doi:10.1021/ol035476c · Cited by 54 · cited 1×
“Some other peptides from marine sources, such as Diazonamide A [65,66], Scleritodermin A [67,68], Hemiasterlin [69–72], Desmethoxymajusculamide C (DMMC) [73] and Milnamide D [74] have been”
BackgroundDidemnin B Induces Cell Death by Apoptosis: The Fastest Induction of Apoptosis Ever Described
Grubb, D. R., Wolvetang, E. J., & Lawen, A. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2580 · Cited by 53
Kulokekahilide-1, a Cytotoxic Depsipeptide from the Cephalaspidean Mollusk Philinopsis speciosa
Kimura, J., Takada, Y., Inayoshi, T., Nakao, Y., Goetz, G., Yoshida, W. Y., & Scheuer, P. J. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo010176z · Cited by 52 · cited 1×
“Kulokekahilide-1 [122], Kulokekahilide-2 [123] and Scopularide A and B [124], also elicit antitumor activity via unknown mechanisms.”
BackgroundBotryllamides A-D, new brominated tyrosine derivatives from styelid ascidians of the genus Botryllus
McDonald, L. A., Swersey, J. C., Ireland, C. M., Carroll, A. R., Coll, J. C., Bowden, B. F., Fairchild, C. R., & Cornell, L. (1995) · Tetrahedron · doi:10.1016/0040-4020(95)00202-j · Cited by 52 · cited 1×
“A lot of peptides were isolated from ascidians, including patellamides [91–94], Styelin D [95], Eusynstyelamide [96], botryllamides A–D (1–4) [97], Lissoclinamides [46,98,99] and Mollamides [100,101] , which display potent cytotoxicity, but their exact mechanism have not been well documented.”
BackgroundCarroll, A. R., Feng, Y., Bowden, B. F., & Coll, J. C. (1996) · The Journal of Organic Chemistry · doi:10.1021/jo951379o · Cited by 50
Maki, A., Diwakaran, H., Redman, B. G., Asfar, S., Pettit, G. R., Mohammad, R. M., & Al-Katib, A. M. (1995) · Anti-Cancer Drugs · doi:10.1097/00001813-199506000-00005 · Cited by 48 · cited 1×
“Dolastatin 10 not only inhibits microtubule assembly, but also induces apoptosis associating with a decrease in Bcl-2 level and an increase in p53 expression in the lymphoma cell line [130].”
BackgroundA novel polypeptide from shark cartilage with potent anti-angiogenic activity
Zheng, L., Ling, P., Wang, Z., Niu, R., Hu, C., Zhang, T., & Lin, X. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.5.4002 · Cited by 48 · cited 1×
“In vitro transwell experiment revealed that the polypeptide inhibited VEGF induced migration and tubulogenesis of human umbilical vein endothelial cells (HUVECs) [89].”
BackgroundSelf-citationIsolation and Structure of Phakellistatin 14 from the Western Pacific Marine Sponge Phakellia sp.,1
Pettit, G. R., & Tan, R. (2005) · Journal of Natural Products · doi:10.1021/np040092w · Cited by 48 · cited 1×
“Phakellistatins Marine sponges Cyclic heptapeptides Unknown [106–109]”
New Geodiamolides from the Sponge Cymbastela sp. Collected in Papua New Guinea
Coleman, J. E., van Soest, R. W. M., & Andersen, R. J. (1999) · Journal of Natural Products · doi:10.1021/np990155o · Cited by 47 · cited 2×
“are a group of cytotoxic peptides in which there is three amino acids forming a cyclic peptide with a common polyketide unit [102,103].”
BackgroundEusynstyelamide, a Highly Modified Dimer Peptide from the Ascidian Eusynstyela misakiensis
Swersey, J. C., Ireland, C. M., Cornell, L. M., & Peterson, R. W. (1994) · Journal of Natural Products · doi:10.1021/np50108a027 · Cited by 46 · cited 2×
“A lot of peptides were isolated from ascidians, including patellamides [91–94], Styelin D [95], Eusynstyelamide [96], botryllamides A–D (1–4) [97], Lissoclinamides [46,98,99] and Mollamides [100,101] , which display potent cytotoxicity, but their exact mechanism have not been well documented.”
BackgroundTaumycins A and B, Two Bioactive Lipodepsipeptides from the Madagascar Sponge Fascaplysinopsis sp.
Bishara, A., Rudi, A., Aknin, M., Neumann, D., Ben‐Califa, N., & Kashman, Y. (2008) · Organic Letters · doi:10.1021/ol801750y · Cited by 46 · cited 1×
“Sponge is another rich resource of peptides, such as Geodiamolides A–G [102,103], Orbiculamide A [104], Koshikamide B [105], Phakellistatins [106–109], Microcionamides A and B [110], Halicylindramides [111], Haligramides [112], Hemiasterlin [113], Milnamide A [114], Corticiamide A [115], Theopapuamide [116], Taumycins…”
BackgroundPan, P., Vasko, R. C., Lapera, S. A., Johnson, V. A., Sellers, R. P., Lin, C.-C., Pan, C., Davis, M. R., Ardi, V. C., & McAlpine, S. R. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.07.017 · Cited by 44 · cited 3×
“Some other peptides from marine sources, such as Sansalvamide A [53,54], Cycloxazoline [55,56] and virenamides A–C [57] have been observed to display potent anti-apoptotic activity in different cancer cells but the exact targets by these chemicals have not yet been identified.”
BackgroundFukushima, K., Murata, M., Hachisuga, M., Tsukimori, K., Seki, H., Takeda, S., Asanoma, K., & Wake, N. (2008) · Placenta · doi:10.1016/j.placenta.2008.01.006 · Cited by 42 · cited 1×
“HIF1α induces VEGF aggregation, actions known to be important for cellular survival and endovascular differentiation [84,85].”
BackgroundHalicylindramides D and E, Antifungal Peptides from the Marine Sponge Halichondria cylindrata
Li, H., Matsunaga, S., & Fusetani, N. (1996) · Journal of Natural Products · doi:10.1021/np9600309 · Cited by 40 · cited 2×
“Sponge is another rich resource of peptides, such as Geodiamolides A–G [102,103], Orbiculamide A [104], Koshikamide B [105], Phakellistatins [106–109], Microcionamides A and B [110], Halicylindramides [111], Haligramides [112], Hemiasterlin [113], Milnamide A [114], Corticiamide A [115], Theopapuamide [116], Taumycins…”
BackgroundPettit, G. R., Xu, J., Cichacz, Z. A., Williams, M. D., Chapuis, J., & Cerny, R. L. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80695-8 · Cited by 40 · cited 1×
“Phakellistatins Marine sponges Cyclic heptapeptides Unknown [106–109]”
Halogenated Cyclic Peptides Isolated from the Sponge Corticium sp.
Laird, D. W., LaBarbera, D. V., Feng, X., Bugni, T. S., Harper, M. K., & Ireland, C. M. (2007) · Journal of Natural Products · doi:10.1021/np060489v · Cited by 38 · cited 1×
“Sponge is another rich resource of peptides, such as Geodiamolides A–G [102,103], Orbiculamide A [104], Koshikamide B [105], Phakellistatins [106–109], Microcionamides A and B [110], Halicylindramides [111], Haligramides [112], Hemiasterlin [113], Milnamide A [114], Corticiamide A [115], Theopapuamide [116], Taumycins…”
BackgroundCaspase Activity Modulators as Anticancer Agents
Okun, I. M., Balakin, K. V., Tkachenko, S. N., & Ivachtchenko, A. V. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008783961914 · Cited by 37 · cited 1×
“Identification of caspases activators becomes another approach for the discovery of novel anticancer agents because caspases are involved in intrinsic and extrinsic apoptosis pathways [23,24].”
BackgroundTotal Synthesis of the Originally Proposed and Revised Structures of Scleritodermin A
Sheng, L., Cui, Y., & Nan, F. (2008) · Organic Letters · doi:10.1021/ol801419m · Cited by 37 · cited 2×
“Scleritodermin A showed significant in vitro cytotoxicity against human tumor cell lines and inhibited tubulin polymerization [67,68].”
BackgroundNakamura, S., Chikaraishi, Y., Tsuruma, K., Shimazawa, M., & Hara, H. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.09.022 · Cited by 36 · cited 4×
“These pathways include VEGF-induced phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), serine/threonine protein kinase family protein kinase B (Akt), two tumor promoters CXC chemokine Receptor (CXCR4) and Hypoxia inducible factor 1alpha (HIF1α) [82,83].”
BackgroundInfluentialTargeting Cellular Proapoptotic Molecules for Developing Anticancer Agents from Marine Sources
Lin, X., Liu, M., Hu, C., & Liao, D. J. (2010) · Current Drug Targets · doi:10.2174/138945010791170824 · Cited by 33 · cited 1×
“Growing evidence shows that most marine anticancer peptides with cytotoxicity may trigger apoptosis by targeting many cellular proteins, and the induced apoptotic process involves both intracellular and extracellular pathways [14].”
BackgroundSelf-citationAndrianasolo, E. H., Goeger, D. E., & Gerwick, W. H. (2007) · Pure and Applied Chemistry · doi:10.1351/pac200779040593 · Cited by 32
Stolze, S. C., Meltzer, M., Ehrmann, M., & Kaiser, M. (2010) · Chemical Communications · doi:10.1039/c0cc02889d · Cited by 32 · cited 1×
“Some other antitumor peptides including Symplocamide A [125,126], Apratoxin D [127,128] and Mitsoamide [129] have been isolated recently from Cyanobacteria.”
BackgroundKoshikamide B, a Cytotoxic Peptide Lactone from a Marine Sponge Theonella sp
Araki, T., Matsunaga, S., Nakao, Y., Furihata, K., West, L. M., Faulkner, D. J., & Fusetani, N. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo801032n · Cited by 31 · cited 2×
“Koshikamide B exhibits cytotoxicity against P388 murine leukemia cells and the human colon tumor (HCT-116) cell line [105].”
BackgroundPettit, G. R., & Tan, R. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01054-5 · Cited by 31
Johnson, K. L., & Lawen, A. (1999) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1999.00821.x · Cited by 30 · cited 1×
“Didemnin B induces death of a variety of transformed cells with apoptotic morphology and DNA fragmentation within the cytosol and the generation of DNA ladders [48], but the exact mechanism for these effects is still obscure [49].”
BackgroundNeovastat (Æ-941) inhibits the airway inflammation via VEGF and HIF-2α suppression
Lee, S. Y., & Chung, S.-M. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2007.08.009 · Cited by 29 · cited 3×
“inhibition [86–88]”
BackgroundInfluentialLin, L. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000393 · Cited by 29 · cited 1×
“Further studies demonstrated that MML increased cell membrane permenbility and inhibition of tubulin polymerization [75].”
BackgroundWatters, D. J., Beamish, H., Marshall, K., Gardiner, R. A., Seymour, G. J., & Lavin, M. F. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686269 · Cited by 28 · cited 5×
“Some other peptides from marine sources, such as Sansalvamide A [53,54], Cycloxazoline [55,56] and virenamides A–”
BackgroundInfluentialKoshikamide A1, a new cytotoxic linear peptide isolated from a marine sponge, Theonella sp.
Fusetani, N., Warabi, K., Nogata, Y., Nakao, Y., Matsunaga, S., & van Soest, R. W. M. (1999) · Tetrahedron Letters · doi:10.1016/s0040-4039(99)00844-8 · Cited by 27 · cited 1×
“Sponge is another rich resource of peptides, such as Geodiamolides A–G [102,103], Orbiculamide A [104], Koshikamide B [105], Phakellistatins [106–109], Microcionamides A and B [110], Halicylindramides [111], Haligramides [112], Hemiasterlin [113], Milnamide A [114], Corticiamide A [115], Theopapuamide [116], Taumycins…”
BackgroundPopulation pharmacokinetics meta-analysis of plitidepsin (Aplidin®) in cancer subjects
Nalda‐Molina, R., Valenzuela, B., Ramón-López, A., Miguel-Lillo, B., Soto-Matos, A., & Ruixo, J. J. P. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0841-4 · Cited by 27 · cited 1×
“Phase II studies are underway [43].”
Yamashita, A., Norton, E. B., Kaplan, J. A., Niu, C., Loganzo, F., Hernandez, R., Beyer, C. F., Annable, T., Musto, S., Discafani, C. M., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.024 · Cited by 26 · cited 1×
“HTI-286 is considered as a potent inhibitor of proliferation and has substantially less interaction with multidrug resistance protein (P-glycoprotein) than currently used antimicrotubule agents [71,72].”
BackgroundKoshikamide A2, a Cytotoxic Linear Undecapeptide Isolated from a Marine Sponge ofTheonellasp.
Araki, T., Matsunaga, S., & Fusetani, N. (2005) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.69.1318 · Cited by 21 · cited 1×
“Sponge is another rich resource of peptides, such as Geodiamolides A–G [102,103], Orbiculamide A [104], Koshikamide B [105], Phakellistatins [106–109], Microcionamides A and B [110], Halicylindramides [111], Haligramides [112], Hemiasterlin [113], Milnamide A [114], Corticiamide A [115], Theopapuamide [116], Taumycins…”
BackgroundPrepatellamide A, a new cyclic peptide from the ascidianLissoclinum patella
Fu, X., Su, J., & Zeng, L. (2000) · Science China Chemistry · doi:10.1007/bf02969512 · Cited by 14
Carroll, A. R., Bowden, B. F., Coll, J. C., Hockless, D., Skelton, B. W., & WHITE, A. H. (1994) · ChemInform · doi:10.1002/chin.199421230 · Cited by 9
Carroll, A. R., Feng, Y., Bowden, B., & Coll, J. C. (1996) · ChemInform · doi:10.1002/chin.199641199 · Cited by 8
[Targeting apoptosis signaling pathways in cancer therapy].
Liang Cheng, C., Wang, X., Zhang, J., Zhang, S., Zheng, S., & Zheng, J. (2009) · PubMed · Cited by 5
Liu, S., Cui, Y., & Nan, F. (2008) · ChemInform · doi:10.1002/chin.200852191 · Cited by 3
Rinehart (2000) · doi:10.1002/(sici)1098-1128(200001)20:1<1::aid-med1>3.0.co;2-a · cited 1×
“Aplidine, also called plitidepsin in clinical trials, is well-tolerated with minor toxicity in finished Phase I clinical trials [40–42].”
Background
Cited by
Sánchez, A., & Vázquez, A. (2017) · Food Quality and Safety · doi:10.1093/fqs/fyx006 · Cited by 868
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. G., & Prinsep, M. R. (2013) · Nat. Prod. Rep. · doi:10.1039/c2np20112g · Cited by 518
Cancer Treatment Using Peptides: Current Therapies and Future Prospects
Thundimadathil, J. (2012) · Journal of Amino Acids · doi:10.1155/2012/967347 · Cited by 491
“Another peptide, ATN-161 (AcPHSCN-NH2), is in early phase II trials for cancer [120].”
BackgroundNovel Bioactive Compounds From Marine Sources as a Tool for Functional Food Development
Ghosh, S., Sarkar, T., Pati, S., Kari, Z. A., Edinur, H. A., & Chakraborty, R. (2022) · Frontiers in Marine Science · doi:10.3389/fmars.2022.832957 · Cited by 271
Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer
Talero, E., García-Mauriño, S., Ávila-Román, J., Rodríguez-Luna, A., Alcaide, A., & Motilva, V. (2015) · Marine Drugs · doi:10.3390/md13106152 · Cited by 255
“Antioxidant Anti-inflammatory Anticancer [67,68]”
Background
Metadata
- Authors
- Zheng, L.-H., Wang, Y.-J., Sheng, J., Wang, F., Zheng, Y., Lin, X.-K., & Sun, M.
- Affiliations
- Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Qingdao 266071, China
- Yellow Sea Fisheries Research Institute (CN)
- Department of Pharmacology, Capital Medical University, Beijing 100069, China
- Corresponding author
- Sun, Mi
- ORCID
- Sheng, Jun
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2011-10-10
- Volume
- 9
- Issue
- 10
- Pages
- 1840-1859
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC3210608
- OpenAlex
- W2100164417
- Cited by
- 146
- References
- 136
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 8 · 2023: 8 · 2022: 11 · 2021: 13 · 2020: 9 · 2019: 9 · 2018: 8 · 2017: 13 · 2016: 8 · 2015: 15 · 2014: 12 · 2013: 12 · 2012: 4
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (30801453)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- anticancer peptides, marine organisms, apoptosis induction, angiogenesis inhibition, mechanism of action, marine biodiversity, anticancer drug discovery
- MeSH terms
- Animals, Antineoplastic Agents, Humans, Microtubules, Mitochondria, Peptides, Tubulin, Apoptosis, Angiogenesis Inhibitors, MAP Kinase Signaling System, Aquatic Organisms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.